Gastrointestinal Involvement in Chronic Granulomatous Disease
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Objective. Chronic granulomatous disease (CGD) is a rare disorder of phagocyte oxidative metabolism. In addition to infectious complications, granulomatous lesions often involve hollow viscera, especially the gastrointestinal (GI) tract. The objective of this study was to evaluate the clinical presentation, prevalence, and consequences of GI involvement in patients with CGD. Methods. The medical records of 140 patients with CGD (67% X-linked) followed at the National Institutes of Health were reviewed and abstracted for GI manifestations. All available GI pathology was reviewed. Results. GI involvement was recorded in 46 (32.8%) of 140 patients with CGD, 89% of whom had X-linked inheritance. The median age at the time of initial GI manifestations was 5 years (range: 0.8–30 years); 70% of the affected patients presented with GI involvement in the first decade of life. Abdominal pain was the most frequent symptom (100%), and hypoalbuminemia was the most frequent sign (70%). Prednisone controlled symptoms and signs in the majority of affected patients, but relapse of symptoms occurred in 71%. GI involvement had no effect on mortality and was unassociated with interferon-γ use. Conclusion. GI involvement is a common and recurring problem in CGD, especially in those with X-linked inheritance. Currently, there is no clear evidence for an infectious cause. The frequency of GI involvement is unaffected by the use of interferon-γ and does not affect mortality. GI involvement should be sought in patients who have CGD with abdominal pain, growth delay, or hypoalbuminemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic Granulomatous Disease: Report on a National Registry of 368 Patients
Winkelstein, J. A., Marino, M. C., Johnston, R. B., Boyle, J., Curnutte, J., Gallin, J. I., Malech, H. L., Holland, S. M., Ochs, H., Quie, P., et al. (2000) · Medicine · doi:10.1097/00005792-200005000-00003 · Cited by 1,728
Self-citationGenetic, Biochemical, and Clinical Features of Chronic Granulomatous Disease
Segal, B. H., Leto, T. L., Gallin, J. I., Malech, H. L., & Holland, S. M. (2000) · Medicine · doi:10.1097/00005792-200005000-00004 · Cited by 883
Self-citationA Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease
The International Chronic Granulomatous Disease Cooperative Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199102213240801 · Cited by 830
Clinical Aspects and Pathophysiology of Inflammatory Bowel Disease
Hendrickson, B. A., Gokhale, R., & Cho, J. H. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.1.79-94.2002 · Cited by 630
Itraconazole to Prevent Fungal Infections in Chronic Granulomatous Disease
Gallin, J. I., Alling, D. W., Malech, H. L., Wesley, R., Koziol, D., Marciano, B., Eisenstein, E. M., Turner, M. L., DeCarlo, E. S., Starling, J. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021931 · Cited by 400
Self-citationThe genetics of inflammatory bowel disease
BONEN, D. (2003) · Gastroenterology · doi:10.1053/gast.2003.50045 · Cited by 369
Trimethoprim-Sulfamethoxazole Prophylaxis in the Management of Chronic Granulomatous Disease
Margolis, D. M., Melnick, D. A., Ailing, D. W., & Gallin, J. I. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.3.723 · Cited by 261
Self-citationFoster, C. B., Lehrnbecher, T., Mol, F., Steinberg, S. M., Venzon, D. J., Walsh, T. J., Noack, D., Rae, J., Winkelstein, J. A., Curnutte, J. T., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci5084 · Cited by 236
Clinical aspects of chronic granulomatous disease
Johnston, R. B. (2001) · Current Opinion in Hematology · doi:10.1097/00062752-200101000-00004 · Cited by 181
Gastrointestinal Manifestations of Chronic Granulomatous Disease
Ament, M. E., & Ochs, H. D. (1973) · New England Journal of Medicine · doi:10.1056/nejm197302222880802 · Cited by 179
Brown, J. R., Goldblatt, D., Buddle, J., Morton, L., & Thrasher, A. J. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1202599 · Cited by 159
Chronic granulomatous disease in adults
Liese, J. G., Jansson, A. F., Petropoulou, T., Kloos, S., Belohradsky, B. H., Jendrossek, V., & Gahr, M. L. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90403-1 · Cited by 145
Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease
Chin, T. W., Stiehm, E. R., Falloon, J., & Gallin, J. I. (1987) · The Journal of Pediatrics · doi:10.1016/s0022-3476(87)80452-3 · Cited by 135
Self-citationColitis in chronic granulomatous disease
Schäppi, M. G., Smith, V. V., Goldblatt, D., Lindley, K. J., & Milla, P. J. (2001) · Archives of Disease in Childhood · doi:10.1136/adc.84.2.147 · Cited by 133
Etiopathogenesis of Inflammatory Bowel Disease: The Importance of the Pediatric Perspective
Oliva‐Hemker, M. M., & Fiocchi, C. (2002) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200203000-00008 · Cited by 98
Colitis in chronic granulomatous disease
Werlin, S. L., Chusid, M. J., Caya, J. G., & Oechler, H. W. (1982) · Gastroenterology · doi:10.1016/0016-5085(82)90023-3 · Cited by 96
Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1)
Szudek, J., Joe, H., & Friedman, J. M. (2002) · Genetic Epidemiology · doi:10.1002/gepi.1129 · Cited by 87
Segal, B. H., Kuhns, D. B., Ding, L., Gallin, J. I., & Holland, S. M. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.3.410 · Cited by 77
Self-citationGastrointestinal Complications of Chronic Granulomatous Disease: Case Report and Literature Review
Barton, L. L., Moussa, S. L., Villar, R. G., & Hulett, R. L. (1998) · Clinical Pediatrics · doi:10.1177/000992289803700403 · Cited by 76
Chronic Granulomatous Disease Mimicking Crohn'S Disease
Isaacs, D., Wright, Y. M., Shaw, D. G., Raafat, F., & Walker-Smith, J. A. (1985) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.1985.tb08886.x · Cited by 70
The Nature of Colitis in Chronic Granulomatous Disease
Schäppi, M. G., Klein, N. J., Lindley, K. J., Rampling, D., Smith, V. V., Goldblatt, D., & Milla, P. J. (2003) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200305000-00006 · Cited by 65
Tsuji, S., Taniuchi, S., Hasui, M., YAMAMOTO, A., & Kobayashi, Y. (2002) · Nitric Oxide · doi:10.1016/s1089-8603(02)00110-6 · Cited by 41
Gastric outlet obstruction due to X-linked chronic granulomatous disease.
Johnson, F. E., Humbert, J. R., Kuzela, D. C., Todd, J. K., & Lilly, J. R. (1975) · PubMed · Cited by 41
IFN- γ Is Effective in Reducing Infections in the Mouse Model of Chronic Granulomatous Disease (CGD)
Jackson, S. H., Miller, G. F., Segal, B. H., Mardiney, M., Domachowske, J. B., Gallin, J. I., & Holland, S. M. (2001) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900152547821 · Cited by 40
Self-citationGastrointestinal complications of chronic granulomatous disease: surgical implications.
Mulholland, M. W., Delaney, J. P., & Simmons, R. L. (1983) · PubMed · Cited by 38
Corticosteroids for chronic granulomatous disease
Quie, P. G., & Belani, K. (1987) · The Journal of Pediatrics · doi:10.1016/s0022-3476(87)80460-2 · Cited by 31
Mitomi, H., Mikami, T., Takahashi, H., Igarashi, M., Katsumata, T., Ihara, A., Ohtani, Y., Ohta, T., & Okayasu, I. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026643609944 · Cited by 26
Intrafamilial correlation of clinical manifestations in neurofibromatosis 2 (NF2)
Zhao, Y., Kumar, R. A., Baser, M. E., Evans, D. G., Wallace, A. J., Kluwe, L., Mautner, V., Parry, D. M., Rouleau, G. A., Joe, H., et al. (2002) · Genetic Epidemiology · doi:10.1002/gepi.10181 · Cited by 26
Stature and weight in chronic granulomatous disease
Buescher, E. S., & Gallin, J. I. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80497-7 · Cited by 17
Self-citationEEG development in early treated PKU patients from birth to 6 years of age
Pietz, J., Lütcke, A., Sontheimer, D., Benninger, C., Pietz, B., Batzler, U., & Heusser, A. (1990) · European Journal of Pediatrics · doi:10.1007/bf02126296 · Cited by 5
Cited by
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989
Host–microbiota interactions in inflammatory bowel disease
Caruso, R., Lo, B. C., & Núñez, G. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0268-7 · Cited by 780
The Diagnostic Approach to Monogenic Very Early Onset Inflammatory Bowel Disease
Uhlig, H. H., Schwerd, T., Koletzko, S., Shah, N., Kammermeier, J., Elkadri, A., Ouahed, J., Wilson, D. C., Travis, S. P., Turner, D., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.023 · Cited by 715
Chronic Granulomatous Disease: The European Experience
van den Berg, J. M., van Koppen, E., Åhlin, A., Belohradsky, B. H., Bernatowska, E., Corbeel, L., Español, T., Fischer, A., Kurenko-Deptuch, M., Mouy, R., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005234 · Cited by 687
The role of neutrophils during intestinal inflammation
Fournier, B. M., & Parkos, C. A. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.24 · Cited by 671
Metadata
- Authors
- Marciano, B. E., Rosenzweig, S. D., Kleiner, D. E., Anderson, V. L., Darnell, D. N., Anaya-O'Brien, S., Hilligoss, D. M., Malech, H. L., Gallin, J. I., & Holland, S. M.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2004-08-01
- Volume
- 114
- Issue
- 2
- Pages
- 462-468
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2032327249
- Cited by
- 418
- References
- 30
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.